(Q62110695)

English

Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma

clinical trial

In more languages

Statements

0 references

Phase II Study of Melphalan, Arsenic Trioxide, and Ascorbic Acid in Patients With Relapsed or Refractory Multiple Myeloma (English)

0 references

medical condition

multiple myeloma

0 references

0 references

United States of America

0 references

number of participants

0

0 references

research intervention

0 references

arsenic trioxide

0 references

sodium ascorbate

0 references

clinical trial phase

phase II clinical trial

0 references

Oncotherapeutics (United States)

0 references

Icahn School of Medicine at Mount Sinai

0 references

University of Pennsylvania

0 references

Hackensack University Medical Center

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62110695&oldid=1857061226"